Literature DB >> 14711462

Pain management in cancer patients with bone metastases remains a challenge.

Vivian Yau, Edward Chow, Lori Davis, Lori Holden, Trudi Schueller, Cyril Danjoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14711462     DOI： 10.1016/j.jpainsymman.2003.10.003

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  11 in total

1.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain during participation in a psychoeducational intervention study to improve pain management.

Authors:  Dale J Langford; Steven M Paul; Debu Tripathy; Claudia West; Marylin J Dodd; Karen Schumacher; Christine Miaskowski
Journal:  J Pain       Date:  2011-03-22       Impact factor: 5.820

2.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

3.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain.

Authors:  Dale J Langford; Debu Tripathy; Steven M Paul; Claudia West; Marylin J Dodd; Karen Schumacher; Christine Miaskowski
Journal:  J Pain       Date:  2011-02-18       Impact factor: 5.820

Review 4.  Bisphosphonates for malignancy-related bone disease: current status, future developments.

Authors:  Jean-Jacques Body
Journal:  Support Care Cancer       Date:  2006-02-01       Impact factor: 3.603

Review 5.  Metastatic bone pain: treatment options with an emphasis on bisphosphonates.

Authors:  Roger von Moos; Florian Strasser; Silke Gillessen; Kathrin Zaugg
Journal:  Support Care Cancer       Date:  2008-08-06       Impact factor: 3.603

Review 6.  The management of painful bone metastases with an emphasis on radionuclide therapy.

Authors:  Darren J Hillegonds; Stephen Franklin; David K Shelton; Srinivasan Vijayakumar; Vani Vijayakumar
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

7.  Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease.

Authors:  Kyriaki Mystakidou; Evangelia Stathopoulou; Efi Parpa; Vassilios Kouloulias; Evangelia Kouskouni; Lambros Vlahos
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-27       Impact factor: 4.553

8.  Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.

Authors:  L Bianchi; A Baroli; L Marzoli; C Verusio; C Chiesa; L Pozzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-28       Impact factor: 9.236

9.  Comparative Therapeutic Efficacy of 153Sm-EDTMP and 177Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients' Pain Score Analysis and Personalized Dosimetry.

Authors:  Sarika Sharma; Baljinder Singh; Ashwani Koul; Bhagwant Rai Mittal
Journal:  Front Med (Lausanne)       Date:  2017-05-01

10.  Cancer-Related Pain: Prevalence, Severity and Management in a Tertiary Care Center in the Middle East

Authors:  Nadine M Hamieh; Reem Akel; Bilal Anouti; Cindy Traboulsi; Iman Makki; Lana Hamieh; Arafat Tfayli
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.